Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$12,800,318
+$3,011,206 QoQ
Shares Held
10,672
+0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#1,126
of 4,601 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MidFirst Bank holds $52,023,378 across 15 Drug Manufacturers - General names. LLY ranks #2 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
59,477 | $15,105,373 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
10,672 | $12,800,318 | |
| 3 | ABBV |
AbbVie Inc.
|
41,007 | $10,319,001 | |
| 4 | AMGN |
Amgen Inc
|
25,893 | $9,376,373 | |
| 5 | SNY |
Sanofi
|
45,215 | $1,928,871 | |
| 6 | MRK |
Merck & Co., Inc.
|
11,438 | $1,469,783 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,414 | $810,344 | |
| 8 | PFE |
Pfizer Inc
|
6,366 | $153,293 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,800,318 | 10,672 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $9,789,112 | 10,643 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,896,181 | 10,139 | Shares | Sole | 2026-02-25 | |
| No filing history on record for this holder in this stock. | ||||||